House Approves Right-To-Try Legislation Despite Serious Patient Safety Concerns
The House of Representatives tonight passed legislation that would change the process for accessing experimental drugs without including necessary patient safeguards. The Right-to-Try legislation was opposed by the American Cancer Society Cancer Action Network (ACS CAN) along with more than 80 other organizations representing millions of patients.